HomeLUPIN • NSE
add
Lupin Ltd
Nakaraang pagsara
₹1,954.80
Sakop ng araw
₹1,957.00 - ₹1,996.00
Sakop ng taon
₹1,651.15 - ₹2,402.90
Market cap
902.50B INR
Average na Volume
990.11K
P/E ratio
27.69
Dividend yield
-
Primary exchange
NSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 56.67B | 14.24% |
Gastos sa pagpapatakbo | 29.68B | 34.53% |
Net na kita | 7.73B | 114.93% |
Net profit margin | 13.63 | 88.00% |
Kita sa bawat share | 16.87 | 114.63% |
EBITDA | 13.05B | 41.04% |
Aktuwal na % ng binabayarang buwis | 12.67% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 42.01B | 106.51% |
Kabuuang asset | 292.05B | 21.70% |
Kabuuang sagutin | 119.11B | 23.76% |
Kabuuang equity | 172.94B | — |
Natitirang share | 456.30M | — |
Presyo para makapag-book | 5.18 | — |
Return on assets | — | — |
Return on capital | 12.08% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 7.73B | 114.93% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis. Wikipedia
Itinatag
1968
Headquarters
Website
Mga Empleyado
19,210
